Rubicon Genomics has announced it is merging with Takara Bio USA Holdings Inc. which is acquiring the company along with all outstanding capital stock for $75 million.
To ensure receipt of our emails, please add mlive.com_newsletters@update.mlive.com to your address book or safe sender list. You received this email because you opted-in to the newsletter. MLive Media Group 169 Monroe NW #100, Grand Rapids MI 49503
